VEA
Vanguard FTSE Developed Markets Index Fund ETF Shares
Vanguard FTSE Developed Markets Index Fund ETF Shares historical holders
total: 2
Causeway Capital Management Vanguard FTSE Developed Markets Index Fund ETF Shares transactions over time
- Total transactions:
- 16
- New positions:
- 1
- Added:
- 7
- Reduced:
- 8
- Held since:
- 2022 Q2
- Held for:
- 16 quarters
- Latest activity:
- 2026 Q1
Sarah Ketterer has been an institutional investor in Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) since 2022 Q2. According to 2026 Q1 report, Sarah Ketterer holds 736,637 shares with a market value of roughly $47.20M representing 0.58% of their equity portfolio. The fund/company first acquired VEA in 2022 Q2, initially purchasing 511,822 shares. Since the initial investment, Causeway Capital Management has made 15 more transactions in this position.
Does Sarah Ketterer still hold VEA?
Yes, Sarah Ketterer continues to hold Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA). According to their 2026 Q1 report, they maintain a position of 736,637 shares valued at approximately $47.20M, representing 0.58% of their equity portfolio.
When did Sarah Ketterer first invest in VEA?
Sarah Ketterer first invested in Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) in 2022 Q2 at the reported quarter-end price of $40.80 per share, acquiring 511,822 shares in their initial purchase.
What is Sarah Ketterer's average cost basis for VEA?
Based on historical transaction data, Sarah Ketterer's estimated cost basis for Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) is approximately $49.55 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $49.55
- Weighted AVG sell price:
- $50.10
VEA transactions history by Causeway Capital Management
16 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.58%
|
736,637
|
$64.08
|
$47,203,675
|
+74.81% (+315,245)
|
+0.25%
|
|
2025 Q4
|
0.36%
|
421,392
|
$62.47
|
$26,324,368
|
-17.13% (-87,112)
|
-0.07%
|
|
2025 Q3
|
0.40%
|
508,504
|
$59.92
|
$30,469,580
|
+107.43% (+263,362)
|
+0.21%
|
|
2025 Q2
|
0.22%
|
245,142
|
$57.01
|
$13,975,524
|
-39.61% (-160,761)
|
-0.19%
|
|
2025 Q1
|
0.43%
|
405,903
|
$50.83
|
$20,632,055
|
-67.95% (-860,458)
|
-1%
|
|
2024 Q4
|
1.38%
|
1,266,361
|
$47.82
|
$60,557,392
|
+160.82% (+780,830)
|
+0.85%
|
|
2024 Q3
|
0.63%
|
485,531
|
$52.81
|
$25,640,884
|
-26.89% (-178,618)
|
-0.26%
|
|
2024 Q2
|
0.89%
|
664,149
|
$49.42
|
$32,822,228
|
+77.92% (+290,864)
|
+0.39%
|
|
2024 Q1
|
0.49%
|
373,285
|
$50.17
|
$18,727,706
|
-35.94% (-209,395)
|
-0.27%
|
|
2023 Q4
|
0.71%
|
582,680
|
$47.90
|
$27,910,358
|
+54.17% (+204,731)
|
+0.25%
|
|
2023 Q3
|
0.44%
|
$43.72
|
+93.68% (+182,810)
|
|||
|
2023 Q2
|
0.24%
|
$46.18
|
-16.12% (-37,499)
|
|||
|
2023 Q1
|
0.25%
|
$45.17
|
+3.93% (+8,787)
|
|||
|
2022 Q4
|
0.27%
|
$41.97
|
-38.48% (-139,998)
|
|||
|
2022 Q3
|
0.37%
|
$36.36
|
-28.91% (-147,973)
|
|||
|
2022 Q2
|
0.52%
|
$40.80
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.